Weng RR, Lu HH, Lin CT, Fan CC, Lin RS, Huang TC, Lin SY, Huang
YJ, Juan YH, Wu YC, Hung ZC, Liu C, Lin XH, Hsieh WC, Chiu TY, Liao JC, Chiu
YL, Chen SY, Yu CJ, Tsai HC: Epigenetic modulation of immune
synaptic-cytoskeletal networks potentiates γδ T cell-mediated cytotoxicity in
lung cancer. Nat Commun 12: 2163, 2021
2. Tsai WC, Wu HY, Chiu YL, Yang JY, Pai MF, Wu YR, Lin WY, Hung KY,
Chien KL, Hsu SP, Peng YS: Acute effects of dietary phosphorus intake on
markers of mineral metabolism in hemodialysis patients: post hoc analysis of a
randomized crossover trial. Ren Fail
43: 141-148, 2021
3. Tsai WC, Chiu YL, Wu HY, Sun WH, Tai SJ, Luan CC, Peng YS, Hsu
SP: Boiling for 15 minutes improves nutrient profiles in fishes included in the
diets of dialysis patients. Hemodial Int,
2021
4. Shueng PW, Yu LY, Chiu HC, Chang HC, Chiu YL, Kuo TY, Yen YW, Lo
CL: Early phago-/endosomal escape of platinum drugs via ROS-responsive micelles
for dual cancer chemo/immunotherapy. Biomaterials
276: 121012, 2021
5. Pan SY, Tsai PZ, Chou YH, Chang YT, Chang FC, Chiu YL, Chiang WC,
Hsu T, Chen YM, Chu TS, Lin SL: Kidney pericyte hypoxia-inducible factor
regulates erythropoiesis but not kidney fibrosis. Kidney Int 99: 1354-1368,
2021
6. Pan SY, Chiang WC, Chen YM: The journey from erythropoietin to
2019 Nobel Prize: Focus on hypoxia-inducible factors in the kidney. J Formos Med Assoc 120: 60-67, 2021
7. Chung FF, Wang PY, Lin SC, Lee YH, Wu HY, Lin MH: Shared clinical
decision-making experiences in nursing: a qualitative study. BMC Nurs 20: 85, 2021
8. Chuang YF, Liu YC, Tseng HY, Lin PX, Li CY, Shih MH, Lin KC, Yang
TO, Yan SH, Chiu YL: Urban-rural differences in the prevalence and correlates
of mild cognitive impairment in community-dwelling older adults in Taiwan: The
EMCIT study. J Formos Med Assoc, 2021
9. Chiu YL, Lin WC, Shu KH, Fang YW, Chang FC, Chou YH, Wu CF,
Chiang WC, Lin SL, Chen YM, Wu MS: Alternative Complement Pathway Is Activated
and Associated with Galactose-Deficient IgA(1) Antibody in IgA Nephropathy
Patients. Front Immunol 12: 638309, 2021
10. Yang FJ, Hsieh CY, Shu KH, Chen IY, Pan SY, Chuang YF, Chiu YL,
Yang WS: Plasma Leucine-Rich α-2-Glycoprotein 1 Predicts Cardiovascular Disease
Risk in End-Stage Renal Disease. Sci Rep
10: 5988, 2020
11. Wu CS, Chyuan IT, Chiu YL, Chen WL, Shen CY, Hsu PN: Preserved
specific anti-viral T-cell response but associated with decreased lupus
activity in SLE patients with cytomegalovirus infection. Rheumatology (Oxford) 59: 3340-3349,
2020
12. Wei SY, Pan SY, Li B, Chen YM, Lin SL: Rejuvenation: Turning
back the clock of aging kidney. J Formos
Med Assoc 119: 898-906, 2020
13. Tseng PY, Chen YT, Wang CH, Chiu KM, Peng YS, Hsu SP, Chen KL,
Yang CY, Lee OK: Prediction of the development of acute kidney injury following
cardiac surgery by machine learning. Crit
Care 24: 478, 2020
14. Peng YS, Syu JP, Wang SD, Pan PC, Kung HN: BSA-bounded p-cresyl
sulfate potentiates the malignancy of bladder carcinoma by triggering cell
migration and EMT through the ROS/Src/FAK signaling pathway. Cell Biol Toxicol 36: 287-300, 2020
15. Pai CH, Lin SR, Liu CH, Pan SY, Hsu H, Chen YT, Yen CT, Yu IS,
Wu HL, Lin SL, Lin SW: Targeting fibroblast CD248 attenuates CCL17-expressing
macrophages and tissue fibrosis. Sci Rep
10: 16772, 2020
16. Lin YC, Lai TS, Wu HY, Chou YH, Chiang WC, Lin SL, Chen YM, Chu
TS, Tu YK: Effects and Safety of Statin and Ezetimibe Combination Therapy in
Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis. Clin Pharmacol Ther 108: 833-843, 2020
17. Huang SF, Huang YC, Chang FY, Lin JC, Chiu CH, Chen CW, Wang FD,
Chiu YL, Cheng SH, Cheng CY, Lin YC, Chen CP, Huang CH, Liu PY, Lee YT, Lee CH,
Chen YS, Sy CL, Tseng YT, Hsu CT, Tseng CC, Lee YL, Liu CE, Sytwu HK: Rapid
establishment of a COVID-19 biobank in NHRI by National Biobank Consortium of
Taiwan. Biomed J 43: 314-317, 2020
18. Chou YH, Pan SY, Shao YH, Shih HM, Wei SY, Lai CF, Chiang WC,
Schrimpf C, Yang KC, Lai LC, Chen YM, Chu TS, Lin SL: Methylation in pericytes
after acute injury promotes chronic kidney disease. J Clin Invest 130: 4845-4857,
2020
19. Chiu YL, Tsai WC, Hung RW, Chen IY, Shu KH, Pan SY, Yang FJ,
Ting TT, Jiang JY, Peng YS, Chuang YF: Emergence of T cell immunosenescence in
diabetic chronic kidney disease. Immun
Ageing 17: 31, 2020
20. Chen YT, Hsu H, Lin CC, Pan SY, Liu SY, Wu CF, Tsai PZ, Liao CT,
Cheng HT, Chiang WC, Chen YM, Chu TS, Lin SL: Inflammatory macrophages switch
to CCL17-expressing phenotype and promote peritoneal fibrosis. J Pathol 250: 55-66, 2020
21. Changchien CY, Sung MH, Chang HH, Tsai WC, Peng YS, Chen Y:
Uremic toxin indoxyl sulfate suppresses myocardial Cx43 assembly and expression
via JNK activation. Chem Biol Interact
319: 108979, 2020
22. Yang TO, Chuang YF, Chiu YL: T-cell aging in end-stage renal
disease: an evolving story with CMV. Med
Microbiol Immunol 208: 281-287,
2019
23. Yang TO, Chuang YF, Chiu YL: Correction to: T-cell aging in
end-stage renal disease: an evolving story with CMV. Med Microbiol Immunol 208: 885,
2019
24. Yang JY, Chen L, Peng YS, Chen YY, Huang JW, Hung KY: Icodextrin
Is Associated with a Lower Mortality Rate in Peritoneal Dialysis Patients. Perit Dial Int 39: 252-260, 2019
25. Wang YC, Cheng YJ, Yang JY, Chao CD, Huang JW, Hung KY: Is
dialysis vintage a perioperative risk for end-stage renal disease patients
receiving total knee and hip arthroplasty. J
Orthop Surg (Hong Kong) 27: 2309499019853887,
2019
26. Tsai WC, Wu HY, Peng YS, Hsu SP, Chiu YL, Yang JY, Chen HY, Pai
MF, Lin WY, Hung KY, Chu FY, Tsai SM, Chien KL: Short-Term Effects of
Very-Low-Phosphate and Low-Phosphate Diets on Fibroblast Growth Factor 23 in
Hemodialysis Patients: A Randomized Crossover Trial. Clin J Am Soc Nephrol 14: 1475-1483,
2019
27. Pu CM, Chen YC, Chen YC, Lee TL, Peng YS, Chen SH, Yen YH, Chien
CL, Hsieh JH, Chen YL: Interleukin-6 from Adipose-Derived Stem Cells Promotes
Tissue Repair by the Increase of Cell Proliferation and Hair Follicles in
Ischemia/Reperfusion-Treated Skin Flaps. Mediators
Inflamm 2019: 2343867, 2019
28. Chiu YL, Tsai HH, Lai YJ, Tseng HY, Wu YW, Peng YS, Chiu CM,
Chuang YF: Cognitive impairment in patients with end-stage renal disease:
Accelerated brain aging? J Formos Med
Assoc 118: 867-875, 2019
29. Chi JN, Lai TS, Wu CF, Fu TY, Chou YH, Chiu YL, Lin WC, Chiang
WC, Chen YM, Wu MS: The relationship of anti-phospholipase A2 receptor antibody
and C5a complement with disease activity and short-term outcome in idiopathic
membranous nephropathy. J Formos Med
Assoc 118: 898-906, 2019
30. Chen YY, Chen L, Huang JW, Yang JY: Effects of Early Frequent
Nephrology Care on Emergency Department Visits among Patients with End-stage
Renal Disease. Int J Environ Res Public
Health 16, 2019
31. Changchien CY, Lin YH, Cheng YC, Chang HH, Peng YS, Chen Y:
Indoxyl sulfate induces myotube atrophy by ROS-ERK and JNK-MAFbx cascades. Chem Biol Interact 304: 43-51, 2019
32. Chang HH, Hsu SP, Chien CT: Intrarenal Transplantation of Hypoxic
Preconditioned Mesenchymal Stem Cells Improves Glomerulonephritis through
Anti-Oxidation, Anti-ER Stress, Anti-Inflammation, Anti-Apoptosis, and
Anti-Autophagy. Antioxidants (Basel)
9, 2019
33. Yang FJ, Shu KH, Chen HY, Chen IY, Lay FY, Chuang YF, Wu CS,
Tsai WC, Peng YS, Hsu SP, Chiang CK, Wang G, Chiu YL: Anti-cytomegalovirus IgG
antibody titer is positively associated with advanced T cell differentiation
and coronary artery disease in end-stage renal disease. Immun Ageing 15: 15,
2018
34. Wu HY, Huang JW, Tsai WC, Peng YS, Chen HY, Yang JY, Hsu SP, Pai
MF, Ko MJ, Hung KY, Chiu HC: Prognostic importance and determinants of uremic
pruritus in patients receiving peritoneal dialysis: A prospective cohort study.
PLoS One 13: e0203474, 2018
35. Wu HY, Chien KL, Hung KY: Physician prescribing patterns of
antihypertensives in diabetic patients before and after the implementation of
Taiwan's guideline for the management of hypertension. J Formos Med Assoc 117: 650-651,
2018
36. Tsai WC, Wu HY, Peng YS, Hsu SP, Chiu YL, Chen HY, Yang JY, Ko
MJ, Pai MF, Tu YK, Hung KY, Chien KL: Effects of lower versus higher phosphate
diets on fibroblast growth factor-23 levels in patients with chronic kidney
disease: a systematic review and meta-analysis. Nephrol Dial Transplant 33: 1977-1983,
2018
37. Tsai WC, Peng YS, Wu HY, Hsu SP, Chiu YL, Liu LC, Tsai SM, Chien
KL: Accuracy of a Nutrient Database in Estimating the Dietary
Phosphorus-to-Protein Ratio and Using a Boiling Method in Low-Phosphate
Hospital Diets. Sci Rep 8: 15246, 2018
38. Chiu YL, Shu KH, Yang FJ, Chou TY, Chen PM, Lay FY, Pan SY, Lin
CJ, Litjens NHR, Betjes MGH, Bermudez S, Kao KC, Chia JS, Wang G, Peng YS,
Chuang YF: A comprehensive characterization of aggravated aging-related changes
in T lymphocytes and monocytes in end-stage renal disease: the iESRD study. Immun Ageing 15: 27, 2018
39. Chao CT, Wang J, Wu HY, Huang JW, Chien KL: Age modifies the
risk factor profiles for acute kidney injury among recently diagnosed type 2
diabetic patients: a population-based study. Geroscience 40: 201-217,
2018
40. Yang JY, Huang JW, Chen L, Chen YY, Pai MF, Tung KT, Peng YS,
Hung KY: Frequency of Early Predialysis Nephrology Care
and Postdialysis Cardiovascular Events. Am J Kidney Dis 70: 164-172,
2017
41. Wu HY, Peng CL, Chen PC, Chiang CK, Chang CJ, Huang JW, Peng YS,
Tu YK, Chu TS, Hung KY, Chien KL: Comparative effectiveness of
angiotensin-converting enzyme inhibitors versus angiotensin II receptor
blockers for major renal outcomes in patients with diabetes: A 15-year cohort
study. PLoS One 12: e0177654, 2017
42. Wu HY, Fukuma S, Shimizu S, Norton EC, Tu YK, Hung KY, Chen MR,
Chien KL, Fukuhara S: Effects of Higher Quality of Care on Initiation of
Long-term Dialysis in Patients With CKD and Diabetes. Am J Kidney Dis 70: 666-674,
2017
43. Wu HY: Omission of Data and Errors in Meta-analysis. JAMA Intern Med 177: 1694-1695, 2017
44. Tsai WC, Wu HY, Peng YS, Yang JY, Chen HY, Chiu YL, Hsu SP, Ko
MJ, Pai MF, Tu YK, Hung KY, Chien KL: Association of Intensive Blood Pressure
Control and Kidney Disease Progression in Nondiabetic Patients With Chronic
Kidney Disease: A Systematic Review and Meta-analysis. JAMA Intern Med 177: 792-799,
2017
45. Tsai WC, Chien KL, Wu HY: Intensive Blood Pressure Control in
Autosomal Dominant Polycystic Kidney Disease-How Safe Is It?-Reply. JAMA Intern Med 177: 1695-1696, 2017
46. Shu KH, Chiang WC, Chiu YL: Anti-CD20 therapy and pauci-immune
crescentic glomerulonephritis. J Formos
Med Assoc 116: 215-216, 2017
47. Pan SY, Chiang WC, Chen PM, Liu HH, Chou YH, Lai TS, Lai CF,
Chiu YL, Lin WY, Chen YM, Chu TS, Lin SL: Restricted Use of
Erythropoiesis-Stimulating Agent is Safe and Associated with Deferred Dialysis
Initiation in Stage 5 Chronic Kidney Disease. Sci Rep 7: 44013, 2017
48. Lee JJ, Kao KC, Chiu YL, Jung CJ, Liu CJ, Cheng SJ, Chang YL, Ko
JY, Chia JS: Enrichment of Human CCR6(+) Regulatory T Cells with Superior
Suppressive Activity in Oral Cancer. J
Immunol 199: 467-476, 2017
49. Kao CC, Yang JY, Chen L, Chao CT, Peng YS, Chiang CK, Huang JW,
Hung KY: Factors associated with poor outcomes of continuous renal replacement
therapy. PLoS One 12: e0177759, 2017
50. Chou YH, Huang TM, Pan SY, Chang CH, Lai CF, Wu VC, Wu MS, Wu
KD, Chu TS, Lin SL: Renin-Angiotensin System Inhibitor is Associated with Lower
Risk of Ensuing Chronic Kidney Disease after Functional Recovery from Acute
Kidney Injury. Sci Rep 7: 46518, 2017
